ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006

Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed

December 12, 1975

NEJM Paper: Ownership of IMRT Centers Prompts Urologists to Refer Patients to Radiation Therapy

October 25, 2013

Government Shutdown Cancels NCI Site Visit To Mayo Cancer Center

October 11, 2013

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012